4AB:ETR
AbbVie Common Stock
234,10 €
arrow_upward
+1,34%(+3,10) 1 d.
5. okt., 15:31:04 GMT+2 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4AB…
Atvērt
234,80 €
Augsta
235,10 €
Zema
232,40 €
Tirgus kapitalizācija
463,14 mljrd.
Vid. apjoms
664,00
Apjoms
266,00
Augstākā 52 ned.
237,60 €
Zemākā 52 ned.
162,85 €
Darbinieku skaits
57 tūkst.
Atvērt
234,80 €
Augsta
235,10 €
Zema
232,40 €
Tirgus kapitalizācija
463,14 mljrd.
Vid. apjoms
664,00
Apjoms
266,00
Augstākā 52 ned.
237,60 €
Zemākā 52 ned.
162,85 €
Darbinieku skaits
57 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
AD HOC NEWS
·
pirms 1 stundas
AbbVie stock heads toward October 30 results after 10.2 percent growth
Yahoo Finance
·
pirms 6 stundām
AbbVie Announced Its 340B Rebate Pilot on October 2. Here’s What It Means for the Stock Before Vraylar’s 2027 Medicare Price Cut
AD HOC NEWS
·
pirms 6 stundām
BofA raises target for AbbVie stock to USD 289.00
AD HOC NEWS
·
pirms 8 stundām
AbbVie stock pre-market at EUR 234.20: plus 0.28 percent
Profils
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Par “AbbVie Common Stock”
ĢenerāldirektorsRobert A. Michael
Darbinieki57 tūkst.
Dibināšanas datums2012. gada 10. apr.
Galvenais birojsNorth Chicago, Ilinoisa, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneabbvie.com